MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Decreased DTI-ALPS Indices and their Association with Clinical Features in Parkinson’s Disease

    J. Pardo, I. Roura, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, J. Oltra, A. Campabadal, N. Bargalló, MA. Jurado, M. Garolera, MJ. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

    Objective: To investigate possible glymphatic dysfunction using diffusion tensor image along the perivascular space (DTI-ALPS) in patients with Parkinson’s disease and their relationship with clinical…
  • 2025 International Congress

    Subthalamic nucleus DBS outcomes correlate with white matter tractography in Parkinson’s Disease

    I. Campbell, V. Del Bene, R. Martin, C. Gonzalez, S. Brinkerhoff, M. Wade, B. Hill, H. Walker, V. Mishra (Mobile, USA)

    Objective: To assess whether advanced diffusion magnetic resonance imaging (dMRI) techniques help to understand the outcome of Deep brain stimulation (DBS) surgery on Unified Parkinson’s…
  • 2025 International Congress

    Scans Without Evidence of Dopamine Deficiency (SWEDD) in Early-Onset Parkinson’s Disease: Comprehensive Clinical Analysis

    A. Zare Dehnavi, C. Piat, A. Mullan, P. Turcano, E. Camerucci, M. Derhab, R. Savica (Rochester, USA)

    Objective: Aim of this study is to comprehensively compare motor and non-motor symptoms of individuals with Early Onset Parkinson's Disease (EOPD) with dopamine deficiency to…
  • 2025 International Congress

    Genetic Correlations Between Parkinson’s Disease and Circulating Metabolites

    M. Tan, T. Ascencio, S. Rodriguez-Quiroga, J. Largo González, S. Peña Martinez, L. Hernandez Delgado, A. Noyce (San Salvador, El Salvador)

    Objective: To use genome-wide association studies (GWASs) to identify genetic correlations between Parkinson’s disease (PD) and circulating metabolites. Background: Metabolomics is the study of small…
  • 2025 International Congress

    Returning Secondary Health Findings in the PD GENEration study

    M. Dini, K. Ghosh Galvelis, N. Bothwick, L. Caboy, M. Caulfield, R. de Leon, A. Dilliott, I. Khaderi, S. Rao, A. Yake, A. Coral Zambrano, R. Bhisetti, S. Lawrence, S. Li, Y. Lu, U. Ragunathan, T. Foroud, V. Caceres, L. Cook, K. Fiallos, L. Heathers, R. Hodges, A. Miller, A. Neibaur, M. Rumbaugh, M. Totten, J. Verbrugge, A. Hall, K. Marder, I. Mata, N. Mencacci, M. Nance, T. Simuni, M. Schwarzschild, A. Wills, H. Gao, C. Blauwendraat, J. Beck, R. Alcalay (Miami, USA)

    Objective: To provide secondary health findings (SHF) results to participants enrolled in the PD GENEration study via CLIA genetic testing using whole genome sequencing (WGS)…
  • 2025 International Congress

    A unique genetic duality: GAK and SCN4A Mutations in Myasthenic Syndrome and Early-Onset Parkinsonism in a Peruvian woman: A Case Report

    W. Trillo Alvarez, A. Carpio Peña, L. Delgado Villanueva, A. Gomez Azcue, H. Paz-Soldan Candia, M. Nieto Rosas, D. Flores Barragan, F. Arismendi Gomez (AREQUIPA, Peru)

    Objective: To present the first genetically characterized non-linear summative damage characterized case resulting in early-onset parkinsonism associated with congenital myasthenia Background: The GAK (Cyclin G…
  • 2025 International Congress

    Monogenic Parkinson’s Disease patients in Central Europe within the CEGEMOD consortium

    M. Ostrozovicova, G. Tamas, P. Dusek, M. Grofik, V. Han, P. Holly, R. Jech, P. Klivenyi, N. Kovacs, E. Kurca, A. Lackova, J. Necpal, D. Pinter, E. Ruzicka, T. Serranova, K. Smilowska, I. Straka, T. Svorenova, P. Valkovic, K. Zarubova, H. Houlden, M. Rizig, M. Skorvanek (Kosice, Slovakia)

    Objective: To report the genetic results of genotyping and whole-exome sequencing (WES) data of patients with Parkinson’s disease (PD) from the Central European countries of…
  • 2025 International Congress

    Genetic risk modifiers for GBA1 carriers in Parkinson’s disease: from the Global Parkinson’s Genetics Program

    GP2. Parkinson'S_genetics_program (gp2) (Chevy Chase, USA)

    Objective: To identify potential genetic risk modifiers for GBA1 variant carriers across genetically determined European ancestries (European, Ashkenazi Jewish, Finnish, and Icelandic) using data from…
  • 2025 International Congress

    Histopathology of long-term implants of peripheral nerve tissue into the substantia nigra of patients with Parkinson’s disease

    J. Quintero, A. Marlonsson, A. Granholm, G. Gerhardt, C. van Horne (Lexington, USA)

    Objective: To characterize autologous peripheral nerve tissue (PNT) implants into the substantia nigra of individuals with PD who participated in our previous clinical trials. Background:…
  • 2025 International Congress

    Motor Outcomes Following Subthalamic Nucleus or Globus Pallidus Interna Deep Brain Stimulation in Early-Onset Parkinson’s Disease

    G. Hey, H. Kamo, G. Rodriguez Garcia, T. Mehta, J. Hilliard, R. Eisinger, A. Ramirez-Zamora (Gainesville, USA)

    Objective: Comparative outcomes between deep brain stimulation (DBS) targets in Early-onset Parkinson’s Disease (EOPD) patients are lacking. This study leverages the University of Florida’s (UF)…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley